Daniel W. Gil

Person

Corona Del Mar, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)eth...
- Patent number 11,331,306
- Issue date May 17, 2022
- Allergan, Inc.
- Mohammed I. Dibas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Alpha-2-adrenergic receptor agonists for treatment of presbyopia, v...
- Patent number 11,077,053
- Issue date Aug 3, 2021
- Allergan, Inc.
- Mohammed Dibas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heavy chain only antibodies to ANG-2
- Patent number 11,046,756
- Issue date Jun 29, 2021
- Allergan, Inc.
- Yanbin Liang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heavy chain only antibodies to PDGF
- Patent number 11,028,163
- Issue date Jun 8, 2021
- Allergan, Inc.
- Yanbin Liang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)eth...
- Patent number 10,555,933
- Issue date Feb 11, 2020
- Allergan, Inc.
- Mohammed I. Dibas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heavy chain only antibodies to PDGF
- Patent number 10,308,711
- Issue date Jun 4, 2019
- Allergan, Inc.
- Yanbin Liang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heavy chain only antibodies to ANG-2
- Patent number 10,266,589
- Issue date Apr 23, 2019
- Allergan, Inc.
- Yanbin Liang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of activating regulatory T cells with alpha-2B adrenergic re...
- Patent number 10,251,865
- Issue date Apr 9, 2019
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical compositions comprising 7-(1H-imidazol-4-ylmethyl)-5...
- Patent number 10,201,535
- Issue date Feb 12, 2019
- Allergan, Inc.
- Mohammed I. Dibas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Alpha-2 adrenergic agonist having long duration of intraocular pres...
- Patent number 9,889,088
- Issue date Feb 13, 2018
- Allergan, Inc.
- Mohammed I. Dibas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating α adrenergic mediated conditions
- Patent number 9,849,113
- Issue date Dec 26, 2017
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of inflammatory bowel disease
- Patent number 9,637,467
- Issue date May 2, 2017
- Allergan, Inc.
- Yariv Donde
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating α adrenergic mediated conditions
- Patent number 9,623,006
- Issue date Apr 18, 2017
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating diseases of the retina
- Patent number 9,561,234
- Issue date Feb 7, 2017
- Allergan, Inc.
- Jyotirmoy Kusari
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical compositions comprising (3-(1-(1H-imidazol-4-yl)ethy...
- Patent number 9,555,021
- Issue date Jan 31, 2017
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of activating regulatory T cells with alpha-2B adrenergic re...
- Patent number 9,545,394
- Issue date Jan 17, 2017
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Alpha adrenergic receptor modulators
- Patent number 9,522,150
- Issue date Dec 20, 2016
- Allergan, Inc.
- Ken Chow
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-...
- Patent number 9,308,201
- Issue date Apr 12, 2016
- Allergan, Inc.
- Mohammed I. Dibas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of activating regulatory T cells with alpha-2B adrenergic re...
- Patent number 9,289,420
- Issue date Mar 22, 2016
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-...
- Patent number 9,283,217
- Issue date Mar 15, 2016
- Allergan, Inc.
- Mohammed I. Dibas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical compositions comprising (3-(1-(1H-imidazol-4-yl)ethy...
- Patent number 9,193,690
- Issue date Nov 24, 2015
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of inflammatory bowel disease
- Patent number 9,156,810
- Issue date Oct 13, 2015
- Allergan, Inc.
- Yariv Donde
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)eth...
- Patent number 9,095,576
- Issue date Aug 4, 2015
- Allergan, Inc.
- Mohammed I. Dibas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Alpha adrenergic receptor modulators
- Patent number 9,040,532
- Issue date May 26, 2015
- Allergan, Inc.
- Ken Chow
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating alpha adrenergic mediated conditions
- Patent number 9,034,910
- Issue date May 19, 2015
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for treating diseases of the retina
- Patent number 9,018,202
- Issue date Apr 28, 2015
- Allergan, Inc.
- Jyotirmoy Kusari
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ester pro-drugs of [3-(1-(1H-imidazol-4-YL)ethyl)-2-methylphenyl] m...
- Patent number 8,853,251
- Issue date Oct 7, 2014
- Allergan, Inc.
- Mohammed I. Dibas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic compounds
- Patent number 8,815,923
- Issue date Aug 26, 2014
- Allergan, Inc.
- Santosh C. Sinha
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Geminal dialkyl prostanoids
- Patent number 8,754,122
- Issue date Jun 17, 2014
- Allergan, Inc.
- Yariv Donde
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] m...
- Patent number 8,653,123
- Issue date Feb 18, 2014
- Allergan, Inc.
- Mohammad I. Dibas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
USE OF ALPHA-2-ADRENERGIC RECEPTOR AGONISTS FOR IMPROVING VISION
- Publication number 20240358682
- Publication date Oct 31, 2024
- Allergan, Inc.
- Mohammed Dibas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HEAVY CHAIN ONLY ANTIBODIES TO PDGF
- Publication number 20240043518
- Publication date Feb 8, 2024
- Allergan, Inc.
- Yanbin Liang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
- Publication number 20230062049
- Publication date Mar 2, 2023
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ALPHA-2-ADRENERGIC RECEPTOR AGONISTS FOR IMPROVING VISION
- Publication number 20220288031
- Publication date Sep 15, 2022
- Allergan, Inc.
- Mohammed Dibas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATMENT OF PRESBYOPIA
- Publication number 20220273557
- Publication date Sep 1, 2022
- Allergan Sales, LLC
- Mohammed Dibas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS COMPRISING 4-[1-(2,3-DIMETHYLPHENYL)ETH...
- Publication number 20220233505
- Publication date Jul 28, 2022
- Allergan, Inc.
- Mohammed I. Dibas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF ALPHA-2-ADRENERGIC RECEPTOR AGONISTS FOR IMPROVING VISION
- Publication number 20220160623
- Publication date May 26, 2022
- Allergan, Inc.
- Mohammed Dibas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HEAVY CHAIN ONLY ANTIBODIES TO PDGF
- Publication number 20220098295
- Publication date Mar 31, 2022
- Allergan, Inc.
- Yanbin Liang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHARMACEUTICAL COMPOSITIONS COMPRISING (3-(1-(1H-IMIDAZOL-4-YL)ETHY...
- Publication number 20220008393
- Publication date Jan 13, 2022
- Allergan, Inc.
- Mohammed I. Dibas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HEAVY CHAIN ONLY ANTIBODIES TO ANG-2
- Publication number 20210324064
- Publication date Oct 21, 2021
- Allergan, Inc.
- Yanbin Liang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THE USE OF ALPHA-2-ADRENERGIC RECEPTOR AGONISTS FOR IMPROVING VISION
- Publication number 20210205273
- Publication date Jul 8, 2021
- Allergan, Inc.
- Mohammed Dibas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF ALPHA-2-ADRENERGIC RECEPTOR AGONISTS FOR IMPROVING VISION
- Publication number 20210059930
- Publication date Mar 4, 2021
- Allergan, Inc.
- Mohammed Dibas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS COMPRISING 4-[1-(2,3-DIMETHYLPHENYL)ETH...
- Publication number 20200390747
- Publication date Dec 17, 2020
- Allergan, Inc.
- Mohammed I. Dibas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
- Publication number 20200330428
- Publication date Oct 22, 2020
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS COMPRISING (3-(1-(1H-IMIDAZOL-4-YL)ETHY...
- Publication number 20200206193
- Publication date Jul 2, 2020
- Allergan, Inc.
- Mohammed I. Dibas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HEAVY CHAIN ONLY ANTIBODIES TO PDGF
- Publication number 20200123240
- Publication date Apr 23, 2020
- Allergan, Inc.
- Yanbin Liang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ALPHA ADRENERGIC AGONISTS FOR THE TREATMENT OF TISSUE TRAUMA
- Publication number 20200054608
- Publication date Feb 20, 2020
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HEAVY CHAIN ONLY ANTIBODIES TO ANG-2
- Publication number 20190248882
- Publication date Aug 15, 2019
- Allergan, Inc.
- Yanbin Liang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHARMACEUTICAL COMPOSITIONS COMPRISING 4-[1-(2,3-DIMETHYLPHENYL)ETH...
- Publication number 20190240200
- Publication date Aug 8, 2019
- Allergan, Inc.
- Mohammed I. Dibas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
- Publication number 20180344692
- Publication date Dec 6, 2018
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR ALLEVIATING HISTAMINE-INDEPENDENT PRURITUS USING NEUROT...
- Publication number 20180125951
- Publication date May 10, 2018
- Allergan, Inc.
- Edward Hsia
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF ACTIVATING REGULATORY T CELLS WITH ALPHA-2B ADRENERGIC RE...
- Publication number 20180071259
- Publication date Mar 15, 2018
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
- Publication number 20180071260
- Publication date Mar 15, 2018
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS COMPRISING 7-(1H-IMIDAZOL-4-YLMETHYL)-5...
- Publication number 20170182028
- Publication date Jun 29, 2017
- Allergan, Inc.
- Mohammed I. Dibas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
- Publication number 20170172982
- Publication date Jun 22, 2017
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS COMPRISING (3-(1-(1H-IMIDAZOL-4-YL)ETHY...
- Publication number 20170172983
- Publication date Jun 22, 2017
- Allergan, Inc.
- Mohammed I. Dibas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HEAVY CHAIN ONLY ANTIBODIES TO ANG-2
- Publication number 20170107279
- Publication date Apr 20, 2017
- Allergan, Inc.
- Yanbin Liang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHARMACEUTICAL COMPOSITIONS COMPRISING 7-(1H-IMIDAZOL-4-YLMETHYL)-5...
- Publication number 20170095466
- Publication date Apr 6, 2017
- ALLERGAN,INC
- Mohammed I. Dibas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF ACTIVATING REGULATORY T CELLS WITH ALPHA-2B ADRENERGIC RE...
- Publication number 20170079956
- Publication date Mar 23, 2017
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HEAVY CHAIN ONLY ANTIBODIES TO PDGF
- Publication number 20170044247
- Publication date Feb 16, 2017
- Allergan, Inc.
- Yanbin Liang
- C07 - ORGANIC CHEMISTRY

Daniel W. Gil

Person

Patents Grantslast 30 patents

Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)eth...

Alpha-2-adrenergic receptor agonists for treatment of presbyopia, v...

Heavy chain only antibodies to ANG-2

Heavy chain only antibodies to PDGF

Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)eth...

Heavy chain only antibodies to PDGF

Heavy chain only antibodies to ANG-2

Method of activating regulatory T cells with alpha-2B adrenergic re...

Pharmaceutical compositions comprising 7-(1H-imidazol-4-ylmethyl)-5...

Alpha-2 adrenergic agonist having long duration of intraocular pres...

Methods of treating α adrenergic mediated conditions

Treatment of inflammatory bowel disease

Methods of treating α adrenergic mediated conditions

Methods for treating diseases of the retina

Pharmaceutical compositions comprising (3-(1-(1H-imidazol-4-yl)ethy...

Method of activating regulatory T cells with alpha-2B adrenergic re...

Alpha adrenergic receptor modulators

Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-...

Method of activating regulatory T cells with alpha-2B adrenergic re...

Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-...

Pharmaceutical compositions comprising (3-(1-(1H-imidazol-4-yl)ethy...

Treatment of inflammatory bowel disease

Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)eth...

Alpha adrenergic receptor modulators

Methods of treating alpha adrenergic mediated conditions

Methods for treating diseases of the retina

Ester pro-drugs of [3-(1-(1H-imidazol-4-YL)ethyl)-2-methylphenyl] m...

Therapeutic compounds

Geminal dialkyl prostanoids

Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] m...

Patents Applicationslast 30 patents

USE OF ALPHA-2-ADRENERGIC RECEPTOR AGONISTS FOR IMPROVING VISION

HEAVY CHAIN ONLY ANTIBODIES TO PDGF

METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS

ALPHA-2-ADRENERGIC RECEPTOR AGONISTS FOR IMPROVING VISION

COMPOSITIONS AND METHODS FOR TREATMENT OF PRESBYOPIA

PHARMACEUTICAL COMPOSITIONS COMPRISING 4-[1-(2,3-DIMETHYLPHENYL)ETH...

USE OF ALPHA-2-ADRENERGIC RECEPTOR AGONISTS FOR IMPROVING VISION

HEAVY CHAIN ONLY ANTIBODIES TO PDGF

PHARMACEUTICAL COMPOSITIONS COMPRISING (3-(1-(1H-IMIDAZOL-4-YL)ETHY...

HEAVY CHAIN ONLY ANTIBODIES TO ANG-2

THE USE OF ALPHA-2-ADRENERGIC RECEPTOR AGONISTS FOR IMPROVING VISION

USE OF ALPHA-2-ADRENERGIC RECEPTOR AGONISTS FOR IMPROVING VISION

PHARMACEUTICAL COMPOSITIONS COMPRISING 4-[1-(2,3-DIMETHYLPHENYL)ETH...

METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS

PHARMACEUTICAL COMPOSITIONS COMPRISING (3-(1-(1H-IMIDAZOL-4-YL)ETHY...

HEAVY CHAIN ONLY ANTIBODIES TO PDGF

ALPHA ADRENERGIC AGONISTS FOR THE TREATMENT OF TISSUE TRAUMA

HEAVY CHAIN ONLY ANTIBODIES TO ANG-2

PHARMACEUTICAL COMPOSITIONS COMPRISING 4-[1-(2,3-DIMETHYLPHENYL)ETH...

METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS

METHODS FOR ALLEVIATING HISTAMINE-INDEPENDENT PRURITUS USING NEUROT...

METHOD OF ACTIVATING REGULATORY T CELLS WITH ALPHA-2B ADRENERGIC RE...

METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS

PHARMACEUTICAL COMPOSITIONS COMPRISING 7-(1H-IMIDAZOL-4-YLMETHYL)-5...

METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS

PHARMACEUTICAL COMPOSITIONS COMPRISING (3-(1-(1H-IMIDAZOL-4-YL)ETHY...

HEAVY CHAIN ONLY ANTIBODIES TO ANG-2

PHARMACEUTICAL COMPOSITIONS COMPRISING 7-(1H-IMIDAZOL-4-YLMETHYL)-5...

METHOD OF ACTIVATING REGULATORY T CELLS WITH ALPHA-2B ADRENERGIC RE...

HEAVY CHAIN ONLY ANTIBODIES TO PDGF